Position in ACHV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$748,103
-$416,154 QoQ
Shares Held
254,457
+8.6% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 81 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 69.6042946352429.ToString("F0")%
Shared 0.ToString("F0")%
None 30.39570536475711.ToString("F0")%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,293,122,197 across 420 Biotechnology names. ACHV ranks #277 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in ACHV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $748,103 | 254,457 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,164,257 | 234,257 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $694,209 | 220,384 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $356,817 | 157,884 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,210,631 | 453,420 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,536,374 | 436,470 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,045,404 | 431,520 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,899,274 | 404,101 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $251,232 | 55,216 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $260,861 | 63,316 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $272,258 | 63,316 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $328,610 | 63,316 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $186,428 | 27,416 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $55,654 | 22,716 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $74,962 | 22,716 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $110,854 | 22,716 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $141,793 | 18,731 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $114,840 | 14,761 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $125,468 | 14,761 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $132,553 | 14,761 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||